ArticleCancer management and research2021

Myelin and Lymphocyte Protein (MAL): A Novel Biomarker for Uterine Corpus Endometrial Carcinoma.

Dong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.